Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 829,777,856
  • Shares Outstanding, K 944,819
  • Annual Sales, $ 65,179 M
  • Annual Income, $ 20,640 M
  • EBIT $ 26,302 M
  • EBITDA $ 28,299 M
  • 60-Month Beta 0.40
  • Price/Sales 13.00
  • Price/Cash Flow 35.68
  • Price/Book 31.96

Options Overview Details

View History
  • Implied Volatility 45.84% (+3.94%)
  • Historical Volatility 30.25%
  • IV Percentile 92%
  • IV Rank 50.36%
  • IV High 64.53% on 04/07/25
  • IV Low 26.88% on 09/04/25
  • Expected Move (DTE 4) 30.52 (3.47%)
  • Put/Call Vol Ratio 1.66
  • Today's Volume 39,566
  • Volume Avg (30-Day) 32,986
  • Put/Call OI Ratio 1.23
  • Today's Open Interest 311,206
  • Open Int (30-Day) 324,015
  • Expected Range 847.73 to 908.76

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 30 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 7.53
  • Number of Estimates 8
  • High Estimate 8.56
  • Low Estimate 6.61
  • Prior Year 3.34
  • Growth Rate Est. (year over year) +125.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
877.11 +0.13%
on 03/27/26
1,056.20 -16.85%
on 03/02/26
-173.75 (-16.52%)
since 02/27/26
3-Month
877.11 +0.13%
on 03/27/26
1,133.95 -22.55%
on 01/08/26
-199.51 (-18.51%)
since 12/26/25
52-Week
623.78 +40.79%
on 08/08/25
1,133.95 -22.55%
on 01/08/26
+56.57 (+6.88%)
since 03/27/25

Most Recent Stories

More News
Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity

Taltz and Zepbound used together provided comprehensive improvements in disease activity and patient-reported outcomes compared to Taltz monotherapy in TOGETHER-PsA study

LLY : 878.24 (-2.09%)
Lilly's EBGLYSS (lebrikizumab-lbkz) delivered up to four years of durable disease control for patients with moderate-to-severe atopic dermatitis

In the ADlong Phase 3b study, nearly all EBGLYSS-treated patients achieved meaningful skin improvement (EASI-75) for up to four years

LLY : 878.24 (-2.09%)
Firing on All Cylinders: Eli Lilly (NYSE:LLY) Q4 Earnings Lead the Way

Firing on All Cylinders: Eli Lilly (NYSE:LLY) Q4 Earnings Lead the Way

LLY : 878.24 (-2.09%)
Want Income and Growth? This Simple 3-ETF Portfolio Does Both

In today’s highly volatile market, this simple 3-ETF portfolio combines both steady income and long-term upside.

MO : 66.48 (+2.88%)
AAPL : 248.80 (-1.62%)
AVGO : 300.68 (-2.82%)
CVX : 211.15 (+1.62%)
VZ : 50.31 (-0.85%)
$SPX : 6,368.85 (-1.67%)
JPM : 282.84 (-3.02%)
JNJ : 240.45 (+0.51%)
SCHD : 30.44 (-0.59%)
ABBV : 209.40 (-0.81%)
BMY : 58.54 (-1.50%)
MSFT : 356.77 (-2.51%)
Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes

For the primary endpoint, retatrutide lowered A1C by an average of 1.7% to 2.0% across doses at 40 weeks in TRANSCEND-T2D-1

LLY : 878.24 (-2.09%)
Members of Congress Bought These 5 Stocks—Should You?

Five stocks recently traded by members of Congress—from AI defense to GLP-1 leaders—could offer clues for investors building their watchlists

SMPL : 14.35 (-0.76%)
AVGO : 300.68 (-2.82%)
CBRL : 26.74 (-3.81%)
BBAI : 3.14 (-5.42%)
LLY : 878.24 (-2.09%)
Why Eli Lilly (LLY) Shares Are Plunging Today

Why Eli Lilly (LLY) Shares Are Plunging Today

LLY : 878.24 (-2.09%)
Stock Indexes Advance as Chip Makers and Travel Stocks Rally

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.25%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.51%. March E-mini...

ALK : 36.16 (-7.16%)
LVS : 51.69 (-1.35%)
WYNN : 96.59 (-2.90%)
ABNB : 122.87 (-6.25%)
STX : 380.07 (+0.34%)
WDC : 275.34 (+0.73%)
SPY : 634.09 (-1.71%)
ADSK : 229.84 (-4.17%)
HON : 223.12 (-0.91%)
MU : 357.22 (+0.50%)
DOV : 206.60 (-1.25%)
AAL : 10.30 (-3.83%)
Stocks Climb on Strength in Chip and Travel Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.64%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.59%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.80%. March E-mini S&P futures (ESH26...

ALK : 36.16 (-7.16%)
LVS : 51.69 (-1.35%)
WYNN : 96.59 (-2.90%)
ABNB : 122.87 (-6.25%)
STX : 380.07 (+0.34%)
WDC : 275.34 (+0.73%)
SPY : 634.09 (-1.71%)
ADSK : 229.84 (-4.17%)
HON : 223.12 (-0.91%)
MU : 357.22 (+0.50%)
DOV : 206.60 (-1.25%)
AAL : 10.30 (-3.83%)
Stocks Supported by Lower Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is up +0.80%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.88%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.93%. March E-mini S&P futures (ESH26...

ALK : 36.16 (-7.16%)
UAL : 88.44 (-4.59%)
INTU : 416.44 (-3.72%)
DDOG : 114.48 (-7.90%)
JHG : 51.38 (-0.02%)
ALGN : 166.38 (-6.17%)
$IUXX : 23,132.77 (-1.93%)
LITE : 702.73 (+2.02%)
ZNM26 : 110-050s (-0.01%)
CIEN : 401.61 (+3.51%)
GLW : 136.81 (+1.10%)
ESM26 : 6,412.25s (-1.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

Relative Strength just crossed below 30%. The market has entered oversold territory.

See More Share

Business Summary

Eli Lilly and Company, one of the world's largest pharmaceutical companies, boasts a diversified product profile including a solid lineup of new successful drugs. It also has a dependable pipeline as it navigates through challenges like patent expirations of several drugs and rising pricing pressure...

See More

Key Turning Points

3rd Resistance Point 917.40
2nd Resistance Point 909.11
1st Resistance Point 893.68
Last Price 878.24
1st Support Level 869.96
2nd Support Level 861.67
3rd Support Level 846.24

See More

52-Week High 1,133.95
Fibonacci 61.8% 939.07
Fibonacci 50% 878.86
Last Price 878.24
Fibonacci 38.2% 818.66
52-Week Low 623.78

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.